Understanding how the main receptor for light interacts with other signaling molecules may inform new pharmaceutical development.

Nobel laureate Andrew Fire, Ph.D., will deliver the next Flexner Discovery Lecture on Thursday, Jan. 24.

Vanderbilt and University of California investigators have discovered the “cell of origin” for pancreatic ductal adenocarcinoma, a finding that could lead to early detection methods and new treatments.

It may be possible to fight hospital-acquired pathogens like Acinetobacter baumannii by targeting the bacterium’s need for the nutrient metal zinc.

Clinical pharmacologist Jens Titze, M.D., and colleagues have discovered that – in contrast to the prevailing dogma – human sodium levels fluctuate rhythmically with 7-day and monthly cycles.

Patients with pancreatic diseases can now access a team of multi-disciplinary specialists with one phone call to the new Vanderbilt Pancreas Center.